NO852721L - Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-fenyl-2-trifluormetyl-1-3-dioksan-5-yl-heptensyre-derivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-fenyl-2-trifluormetyl-1-3-dioksan-5-yl-heptensyre-derivater

Info

Publication number
NO852721L
NO852721L NO852721A NO852721A NO852721L NO 852721 L NO852721 L NO 852721L NO 852721 A NO852721 A NO 852721A NO 852721 A NO852721 A NO 852721A NO 852721 L NO852721 L NO 852721L
Authority
NO
Norway
Prior art keywords
formula
dioxan
cis
compound
trifluoromethyl
Prior art date
Application number
NO852721A
Other languages
English (en)
Norwegian (no)
Inventor
Andrew George Brewster
George Robert Brown
Michael James Smithers
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of NO852721L publication Critical patent/NO852721L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
NO852721A 1984-07-06 1985-07-05 Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-fenyl-2-trifluormetyl-1-3-dioksan-5-yl-heptensyre-derivater NO852721L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848417314A GB8417314D0 (en) 1984-07-06 1984-07-06 Carboxylic acid derivatives

Publications (1)

Publication Number Publication Date
NO852721L true NO852721L (no) 1986-01-07

Family

ID=10563531

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852721A NO852721L (no) 1984-07-06 1985-07-05 Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-fenyl-2-trifluormetyl-1-3-dioksan-5-yl-heptensyre-derivater

Country Status (17)

Country Link
US (1) US4803220A (enExample)
EP (1) EP0177121A3 (enExample)
JP (1) JPS6136278A (enExample)
KR (1) KR860001090A (enExample)
CN (1) CN85105472A (enExample)
AU (1) AU4463385A (enExample)
DK (1) DK307085A (enExample)
ES (1) ES8702397A1 (enExample)
FI (1) FI852658L (enExample)
GB (2) GB8417314D0 (enExample)
GR (1) GR851654B (enExample)
HU (1) HUT38327A (enExample)
IL (1) IL75603A0 (enExample)
NO (1) NO852721L (enExample)
PT (1) PT80775B (enExample)
ZA (1) ZA854564B (enExample)
ZW (1) ZW10185A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
GB8511897D0 (en) * 1985-05-10 1985-06-19 Ici Plc Carboxylic acids
GB8511894D0 (en) 1985-05-10 1985-06-19 Ici Plc Phenol derivatives
HU198706B (en) * 1985-05-10 1989-11-28 Ici Plc Process for producing 1,3-dioxan-ethers and pharmaceutical compositions containing them
GB8611174D0 (en) * 1986-05-08 1986-06-18 Ici Plc Amide derivatives
US5248780A (en) * 1988-02-16 1993-09-28 Imperial Chemical Industries, Plc Pyridyl substituted alkenoic acid derivatives
CA2411887A1 (en) 2000-08-01 2002-02-07 Huntsman International Llc Manufacture of mdi-tdi based flexible polyurethane foams
MX2009007667A (es) * 2007-01-18 2011-12-08 Evolva Sa Profarmacos de 1,3-dioxanos sustituidos y sus usos.
CN101906097B (zh) * 2009-06-02 2012-06-27 首都医科大学 1,3-二氧六环类化合物及其合成方法和在医学中应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids

Also Published As

Publication number Publication date
PT80775A (en) 1985-08-01
ZW10185A1 (en) 1987-02-25
ZA854564B (en) 1986-02-26
DK307085A (da) 1986-01-07
JPS6136278A (ja) 1986-02-20
GR851654B (enExample) 1985-11-26
FI852658A7 (fi) 1986-01-07
HUT38327A (en) 1986-05-28
GB8513906D0 (en) 1985-07-03
EP0177121A2 (en) 1986-04-09
FI852658L (fi) 1986-01-07
PT80775B (en) 1987-02-13
CN85105472A (zh) 1987-01-14
GB8417314D0 (en) 1984-08-08
GB2162512A (en) 1986-02-05
US4803220A (en) 1989-02-07
ES544909A0 (es) 1987-01-01
ES8702397A1 (es) 1987-01-01
FI852658A0 (fi) 1985-07-04
EP0177121A3 (en) 1986-12-03
AU4463385A (en) 1986-01-09
KR860001090A (ko) 1986-02-22
IL75603A0 (en) 1985-10-31
DK307085D0 (da) 1985-07-04

Similar Documents

Publication Publication Date Title
DK163431B (da) Analogifremgangsmaade til fremstilling af 4-phenyl-1,3-dioxan-cis-5-ylalken- eller alkansyrederivater
US4775685A (en) 2,4-diphenyl-1,3-dioxanes
US4803220A (en) Pharmaceutical agents
US5047412A (en) Alkene derivatives
US4735963A (en) Anti-platelet aggregating 1,3-oxathiane derivatives, compositions, and method of use therefor
EP0266980B1 (en) Pharmaceutical compositions, comprising a 2,4-diphenyl-1,3-dioxane derivative and an inhibitor of thromboxane a2 synthesis
US4772625A (en) 1,3-dioxan-5-yl-hexenoic acids
US4831046A (en) Tetrazole derivatives of 1,3-dioxane and thromboxane A2 antigonizing use thereof
US4775684A (en) 1,3-dioxane ethers
US4845120A (en) N-[4-o-hydroxyphenyl-1,3-dioxan-5-ylhexenoyl]sulphonamides
EP0223518B1 (en) Amide derivatives
US4902712A (en) Fluoroalkane derivatives
EP0266979A2 (en) Therapeutic agents
US5126368A (en) Octenoic acid derivatives useful as thromboxane A2 inhibitors